🇺🇸 FDA
Patent

US 9913461

Genetically modified mouse whose genome comprises a humanized CD274 gene

granted A61KA61K2039/505A61K49/0008

Quick answer

US patent 9913461 (Genetically modified mouse whose genome comprises a humanized CD274 gene) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/505, A61K49/0008, A61P, A61P35/00